Archives ipo

by in
Entry Author Date Location
Gelesis, PureTech’s Weight-Loss Hopeful, Postpones IPO 05/13/15 Boston
A123 Systems Drafting Settlement With Apple on “Poaching” Lawsuit 05/12/15 Boston
West Coast Biotech Roundup: Adaptive, Gilead, Juno, aTyr & More 05/08/15 Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Fitbit’s Fitness Open To Scrutiny With IPO Filing 05/07/15 San Francisco
Imprivata Buys HT Systems for $19M for Vein-Identifying Device 05/01/15 Boston
With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect 04/30/15 San Francisco
Intarcia, Still Private, Nabs $225M More For Diabetes Device 04/28/15 Boston
TX Roundup: New Funding, an IPO, Rice Biz Plan winner, & More 04/27/15 Texas
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers 04/21/15 Boston
Why Etsy’s IPO Could Silence Haters of the New York Tech Scene 04/20/15 New York
West Coast Biotech Roundup: CRISPR, Doudna, Aduro, Amgen, NEA & More 04/16/15 San Francisco
Big Day For Biotech IPOs as Aduro More Than Doubles In Price 04/15/15 San Francisco
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
West Coast Biotech Roundup: Amgen/deCODE, Calico, Orexigen & More 03/27/15 San Diego
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
Business Analytics Firm Birst Brings In $65M Series F 03/17/15 San Francisco
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M 03/12/15 Boston
Apple: A123’s Lawsuit “Baseless Conjecture,” Not Actionable Under Law 03/11/15 Boston
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
Early VC Arch Exits Ikaria with $2.3B Sale to Mallinckrodt 03/05/15 New York
Just Eight Days Left—Get Your Seat for “New York’s Life Science Disruptors” 03/04/15 New York
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Page 3 of 17 « previous page · next page »